nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A5—Dactinomycin—muscle cancer	0.172	0.216	CbGbCtD
Desipramine—SLC22A3—Vincristine—muscle cancer	0.17	0.215	CbGbCtD
Desipramine—CYP2E1—Dacarbazine—muscle cancer	0.0994	0.125	CbGbCtD
Desipramine—CYP1A2—Dacarbazine—muscle cancer	0.0575	0.0725	CbGbCtD
Desipramine—CYP2E1—Etoposide—muscle cancer	0.0486	0.0613	CbGbCtD
Desipramine—ABCB1—Dactinomycin—muscle cancer	0.0436	0.0549	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—muscle cancer	0.0327	0.0413	CbGbCtD
Desipramine—CYP1A2—Etoposide—muscle cancer	0.0281	0.0355	CbGbCtD
Desipramine—ABCB1—Vincristine—muscle cancer	0.0268	0.0338	CbGbCtD
Desipramine—ABCB1—Etoposide—muscle cancer	0.0246	0.031	CbGbCtD
Desipramine—ABCB1—Doxorubicin—muscle cancer	0.0168	0.0211	CbGbCtD
Desipramine—ABCB1—Methotrexate—muscle cancer	0.0163	0.0205	CbGbCtD
Desipramine—CYP3A4—Vincristine—muscle cancer	0.0161	0.0203	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—muscle cancer	0.0158	0.0199	CbGbCtD
Desipramine—CYP3A4—Etoposide—muscle cancer	0.0147	0.0186	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—muscle cancer	0.0101	0.0127	CbGbCtD
Desipramine—CHRM3—muscle of abdomen—muscle cancer	0.00929	0.1	CbGeAlD
Desipramine—SLC22A4—larynx—muscle cancer	0.00776	0.0835	CbGeAlD
Desipramine—Paresthesia of limbs—Methotrexate—muscle cancer	0.00392	0.0344	CcSEcCtD
Desipramine—Raised liver function tests—Dactinomycin—muscle cancer	0.00375	0.0329	CcSEcCtD
Desipramine—Ileus paralytic—Vincristine—muscle cancer	0.00358	0.0314	CcSEcCtD
Desipramine—HTR2A—hindlimb—muscle cancer	0.00282	0.0304	CbGeAlD
Desipramine—SMPD1—renal system—muscle cancer	0.00276	0.0297	CbGeAlD
Desipramine—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.00266	0.0234	CcSEcCtD
Desipramine—SMPD1—cardiac atrium—muscle cancer	0.00247	0.0266	CbGeAlD
Desipramine—HTR2A—appendage—muscle cancer	0.00242	0.0261	CbGeAlD
Desipramine—Abdominal cramps—Vincristine—muscle cancer	0.00229	0.0201	CcSEcCtD
Desipramine—SMPD1—tendon—muscle cancer	0.00215	0.0232	CbGeAlD
Desipramine—SMPD1—vagina—muscle cancer	0.002	0.0215	CbGeAlD
Desipramine—Numbness—Vincristine—muscle cancer	0.00187	0.0164	CcSEcCtD
Desipramine—SMPD1—head—muscle cancer	0.00185	0.0199	CbGeAlD
Desipramine—Sensory loss—Vincristine—muscle cancer	0.00179	0.0157	CcSEcCtD
Desipramine—SMPD1—testis—muscle cancer	0.00178	0.0192	CbGeAlD
Desipramine—SLC22A2—renal system—muscle cancer	0.00175	0.0188	CbGeAlD
Desipramine—Raised liver function tests—Methotrexate—muscle cancer	0.00163	0.0143	CcSEcCtD
Desipramine—CYP2C18—vagina—muscle cancer	0.00162	0.0175	CbGeAlD
Desipramine—CHRM4—head—muscle cancer	0.00157	0.0169	CbGeAlD
Desipramine—SLC22A3—embryo—muscle cancer	0.00156	0.0168	CbGeAlD
Desipramine—Tingling sensation—Etoposide—muscle cancer	0.00156	0.0137	CcSEcCtD
Desipramine—CHRM4—testis—muscle cancer	0.00152	0.0163	CbGeAlD
Desipramine—Numbness—Etoposide—muscle cancer	0.00151	0.0133	CcSEcCtD
Desipramine—Sudden death—Methotrexate—muscle cancer	0.00147	0.0129	CcSEcCtD
Desipramine—Sensory loss—Etoposide—muscle cancer	0.00145	0.0127	CcSEcCtD
Desipramine—SLC22A4—renal system—muscle cancer	0.0013	0.014	CbGeAlD
Desipramine—Phosphatase alkaline increased—Etoposide—muscle cancer	0.00125	0.011	CcSEcCtD
Desipramine—SLC22A1—renal system—muscle cancer	0.00124	0.0133	CbGeAlD
Desipramine—SLC22A3—smooth muscle tissue—muscle cancer	0.00123	0.0132	CbGeAlD
Desipramine—CHRM5—head—muscle cancer	0.00123	0.0132	CbGeAlD
Desipramine—SLC22A3—renal system—muscle cancer	0.00118	0.0127	CbGeAlD
Desipramine—Liver function test abnormal—Dactinomycin—muscle cancer	0.00116	0.0102	CcSEcCtD
Desipramine—CYP2A6—vagina—muscle cancer	0.00107	0.0116	CbGeAlD
Desipramine—Urinary retention—Vincristine—muscle cancer	0.00107	0.00938	CcSEcCtD
Desipramine—ADRB1—cardiac atrium—muscle cancer	0.00107	0.0115	CbGeAlD
Desipramine—CHRM3—smooth muscle tissue—muscle cancer	0.00107	0.0115	CbGeAlD
Desipramine—Ataxia—Vincristine—muscle cancer	0.00106	0.00928	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Etoposide—muscle cancer	0.00105	0.00919	CcSEcCtD
Desipramine—CHRM3—renal system—muscle cancer	0.00103	0.011	CbGeAlD
Desipramine—HTR1A—renal system—muscle cancer	0.00102	0.011	CbGeAlD
Desipramine—ORM1—bone marrow—muscle cancer	0.00102	0.011	CbGeAlD
Desipramine—SLC22A4—tendon—muscle cancer	0.00101	0.0109	CbGeAlD
Desipramine—SLC22A4—bone marrow—muscle cancer	0.000982	0.0106	CbGeAlD
Desipramine—Stomatitis—Dactinomycin—muscle cancer	0.000944	0.00829	CcSEcCtD
Desipramine—SLC22A4—vagina—muscle cancer	0.000941	0.0101	CbGeAlD
Desipramine—Petechiae—Methotrexate—muscle cancer	0.000913	0.00802	CcSEcCtD
Desipramine—Agranulocytosis—Dactinomycin—muscle cancer	0.000904	0.00794	CcSEcCtD
Desipramine—SLC22A1—vagina—muscle cancer	0.000896	0.00964	CbGeAlD
Desipramine—Erectile dysfunction—Vincristine—muscle cancer	0.000894	0.00785	CcSEcCtD
Desipramine—Hepatitis—Dactinomycin—muscle cancer	0.00087	0.00764	CcSEcCtD
Desipramine—Depression—Vincristine—muscle cancer	0.000863	0.00758	CcSEcCtD
Desipramine—SLC22A5—renal system—muscle cancer	0.00086	0.00925	CbGeAlD
Desipramine—SLC22A3—vagina—muscle cancer	0.000856	0.00921	CbGeAlD
Desipramine—Acute coronary syndrome—Vincristine—muscle cancer	0.000853	0.00749	CcSEcCtD
Desipramine—Neuropathy peripheral—Vincristine—muscle cancer	0.000848	0.00745	CcSEcCtD
Desipramine—Myocardial infarction—Vincristine—muscle cancer	0.000848	0.00745	CcSEcCtD
Desipramine—Stomatitis—Vincristine—muscle cancer	0.000844	0.00741	CcSEcCtD
Desipramine—CHRM2—head—muscle cancer	0.000843	0.00907	CbGeAlD
Desipramine—SLC6A3—head—muscle cancer	0.00084	0.00904	CbGeAlD
Desipramine—SLC22A1—head—muscle cancer	0.000828	0.00891	CbGeAlD
Desipramine—HTR2C—head—muscle cancer	0.000812	0.00874	CbGeAlD
Desipramine—SLC6A3—testis—muscle cancer	0.000812	0.00873	CbGeAlD
Desipramine—Flushing—Dactinomycin—muscle cancer	0.000807	0.00709	CcSEcCtD
Desipramine—HTR2A—embryo—muscle cancer	0.000805	0.00866	CbGeAlD
Desipramine—ADRB1—head—muscle cancer	0.000797	0.00858	CbGeAlD
Desipramine—SLC22A3—head—muscle cancer	0.000791	0.00851	CbGeAlD
Desipramine—Petechiae—Doxorubicin—muscle cancer	0.00079	0.00694	CcSEcCtD
Desipramine—CYP1A2—renal system—muscle cancer	0.000779	0.00838	CbGeAlD
Desipramine—Hypoaesthesia—Vincristine—muscle cancer	0.000773	0.00679	CcSEcCtD
Desipramine—Hallucination—Vincristine—muscle cancer	0.000773	0.00679	CcSEcCtD
Desipramine—SLC6A4—head—muscle cancer	0.00077	0.00828	CbGeAlD
Desipramine—SLC22A5—cardiac atrium—muscle cancer	0.00077	0.00828	CbGeAlD
Desipramine—Alopecia—Dactinomycin—muscle cancer	0.000769	0.00675	CcSEcCtD
Desipramine—CHRM1—head—muscle cancer	0.000767	0.00825	CbGeAlD
Desipramine—SLC22A3—testis—muscle cancer	0.000764	0.00822	CbGeAlD
Desipramine—HRH1—smooth muscle tissue—muscle cancer	0.000757	0.00815	CbGeAlD
Desipramine—CYP2B6—renal system—muscle cancer	0.000747	0.00803	CbGeAlD
Desipramine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00072	0.00632	CcSEcCtD
Desipramine—Ill-defined disorder—Dactinomycin—muscle cancer	0.000702	0.00617	CcSEcCtD
Desipramine—Nocturia—Doxorubicin—muscle cancer	0.000701	0.00616	CcSEcCtD
Desipramine—CYP2E1—renal system—muscle cancer	0.000701	0.00754	CbGeAlD
Desipramine—Acute coronary syndrome—Etoposide—muscle cancer	0.000691	0.00607	CcSEcCtD
Desipramine—CYP2C19—vagina—muscle cancer	0.000691	0.00743	CbGeAlD
Desipramine—Neuropathy peripheral—Etoposide—muscle cancer	0.000687	0.00604	CcSEcCtD
Desipramine—Myocardial infarction—Etoposide—muscle cancer	0.000687	0.00604	CcSEcCtD
Desipramine—Alopecia—Vincristine—muscle cancer	0.000687	0.00603	CcSEcCtD
Desipramine—CHRM3—head—muscle cancer	0.000686	0.00739	CbGeAlD
Desipramine—HTR1A—head—muscle cancer	0.000684	0.00736	CbGeAlD
Desipramine—Stomatitis—Etoposide—muscle cancer	0.000683	0.006	CcSEcCtD
Desipramine—Jaundice—Etoposide—muscle cancer	0.000683	0.006	CcSEcCtD
Desipramine—Malaise—Dactinomycin—muscle cancer	0.000683	0.006	CcSEcCtD
Desipramine—SLC6A2—head—muscle cancer	0.000678	0.00729	CbGeAlD
Desipramine—Gynaecomastia—Methotrexate—muscle cancer	0.000672	0.0059	CcSEcCtD
Desipramine—SLC22A5—tendon—muscle cancer	0.000671	0.00722	CbGeAlD
Desipramine—Atrioventricular block—Doxorubicin—muscle cancer	0.00067	0.00589	CcSEcCtD
Desipramine—CHRM3—testis—muscle cancer	0.000663	0.00713	CbGeAlD
Desipramine—Coordination abnormal—Doxorubicin—muscle cancer	0.000662	0.00582	CcSEcCtD
Desipramine—SLC6A2—testis—muscle cancer	0.000655	0.00705	CbGeAlD
Desipramine—Agranulocytosis—Etoposide—muscle cancer	0.000654	0.00575	CcSEcCtD
Desipramine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00065	0.00571	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Doxorubicin—muscle cancer	0.00065	0.00571	CcSEcCtD
Desipramine—Discomfort—Dactinomycin—muscle cancer	0.000637	0.00559	CcSEcCtD
Desipramine—HTR2A—smooth muscle tissue—muscle cancer	0.000633	0.00681	CbGeAlD
Desipramine—Hypoaesthesia—Etoposide—muscle cancer	0.000626	0.0055	CcSEcCtD
Desipramine—SLC22A5—vagina—muscle cancer	0.000623	0.0067	CbGeAlD
Desipramine—Agitation—Vincristine—muscle cancer	0.000622	0.00546	CcSEcCtD
Desipramine—Oedema—Dactinomycin—muscle cancer	0.000618	0.00543	CcSEcCtD
Desipramine—DRD2—head—muscle cancer	0.000618	0.00665	CbGeAlD
Desipramine—HTR2A—renal system—muscle cancer	0.000609	0.00655	CbGeAlD
Desipramine—Thrombocytopenia—Dactinomycin—muscle cancer	0.000605	0.00531	CcSEcCtD
Desipramine—DRD2—testis—muscle cancer	0.000597	0.00642	CbGeAlD
Desipramine—Anorexia—Dactinomycin—muscle cancer	0.000589	0.00517	CcSEcCtD
Desipramine—Convulsion—Vincristine—muscle cancer	0.000586	0.00515	CcSEcCtD
Desipramine—Flushing—Etoposide—muscle cancer	0.000584	0.00513	CcSEcCtD
Desipramine—Hypertension—Vincristine—muscle cancer	0.000584	0.00513	CcSEcCtD
Desipramine—HRH1—tendon—muscle cancer	0.000569	0.00612	CbGeAlD
Desipramine—CYP3A4—renal system—muscle cancer	0.000564	0.00607	CbGeAlD
Desipramine—Alopecia—Etoposide—muscle cancer	0.000556	0.00489	CcSEcCtD
Desipramine—Cerebrovascular accident—Methotrexate—muscle cancer	0.000556	0.00489	CcSEcCtD
Desipramine—SLC22A5—testis—muscle cancer	0.000556	0.00598	CbGeAlD
Desipramine—CYP2D6—renal system—muscle cancer	0.000555	0.00597	CbGeAlD
Desipramine—Oedema—Vincristine—muscle cancer	0.000552	0.00485	CcSEcCtD
Desipramine—CYP2E1—tendon—muscle cancer	0.000547	0.00588	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000543	0.00477	CcSEcCtD
Desipramine—CYP2B6—vagina—muscle cancer	0.000541	0.00582	CbGeAlD
Desipramine—Thrombocytopenia—Vincristine—muscle cancer	0.000541	0.00475	CcSEcCtD
Desipramine—Decreased appetite—Dactinomycin—muscle cancer	0.000537	0.00472	CcSEcCtD
Desipramine—Dysgeusia—Etoposide—muscle cancer	0.000537	0.00471	CcSEcCtD
Desipramine—Fatigue—Dactinomycin—muscle cancer	0.000533	0.00468	CcSEcCtD
Desipramine—HRH1—vagina—muscle cancer	0.000528	0.00568	CbGeAlD
Desipramine—Vascular purpura—Doxorubicin—muscle cancer	0.000528	0.00463	CcSEcCtD
Desipramine—ABCB1—embryo—muscle cancer	0.000527	0.00567	CbGeAlD
Desipramine—Anorexia—Vincristine—muscle cancer	0.000526	0.00462	CcSEcCtD
Desipramine—Hypotension—Vincristine—muscle cancer	0.000516	0.00453	CcSEcCtD
Desipramine—Ataxia—Methotrexate—muscle cancer	0.000512	0.0045	CcSEcCtD
Desipramine—Feeling abnormal—Dactinomycin—muscle cancer	0.000509	0.00447	CcSEcCtD
Desipramine—Ill-defined disorder—Etoposide—muscle cancer	0.000508	0.00447	CcSEcCtD
Desipramine—Liver function test abnormal—Methotrexate—muscle cancer	0.000503	0.00442	CcSEcCtD
Desipramine—CYP2B6—head—muscle cancer	0.0005	0.00537	CbGeAlD
Desipramine—Insomnia—Vincristine—muscle cancer	0.000499	0.00439	CcSEcCtD
Desipramine—Paraesthesia—Vincristine—muscle cancer	0.000496	0.00435	CcSEcCtD
Desipramine—Malaise—Etoposide—muscle cancer	0.000494	0.00434	CcSEcCtD
Desipramine—Purpura—Doxorubicin—muscle cancer	0.00049	0.0043	CcSEcCtD
Desipramine—Body temperature increased—Dactinomycin—muscle cancer	0.000488	0.00429	CcSEcCtD
Desipramine—Abdominal pain—Dactinomycin—muscle cancer	0.000488	0.00429	CcSEcCtD
Desipramine—HRH1—head—muscle cancer	0.000488	0.00525	CbGeAlD
Desipramine—CYP2B6—testis—muscle cancer	0.000483	0.00519	CbGeAlD
Desipramine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000482	0.00423	CcSEcCtD
Desipramine—Decreased appetite—Vincristine—muscle cancer	0.00048	0.00422	CcSEcCtD
Desipramine—Fatigue—Vincristine—muscle cancer	0.000476	0.00418	CcSEcCtD
Desipramine—HTR2A—tendon—muscle cancer	0.000475	0.00511	CbGeAlD
Desipramine—Convulsion—Etoposide—muscle cancer	0.000475	0.00417	CcSEcCtD
Desipramine—Hypertension—Etoposide—muscle cancer	0.000473	0.00416	CcSEcCtD
Desipramine—Constipation—Vincristine—muscle cancer	0.000472	0.00415	CcSEcCtD
Desipramine—HRH1—testis—muscle cancer	0.000471	0.00507	CbGeAlD
Desipramine—CYP2E1—head—muscle cancer	0.000469	0.00504	CbGeAlD
Desipramine—Eosinophilia—Methotrexate—muscle cancer	0.000466	0.0041	CcSEcCtD
Desipramine—Discomfort—Etoposide—muscle cancer	0.000461	0.00405	CcSEcCtD
Desipramine—CYP2E1—testis—muscle cancer	0.000453	0.00487	CbGeAlD
Desipramine—Confusional state—Etoposide—muscle cancer	0.000451	0.00396	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—muscle cancer	0.000444	0.0039	CcSEcCtD
Desipramine—Asthenia—Dactinomycin—muscle cancer	0.000443	0.00389	CcSEcCtD
Desipramine—HTR2A—vagina—muscle cancer	0.000441	0.00475	CbGeAlD
Desipramine—Thrombocytopenia—Etoposide—muscle cancer	0.000438	0.00385	CcSEcCtD
Desipramine—Tachycardia—Etoposide—muscle cancer	0.000436	0.00383	CcSEcCtD
Desipramine—Body temperature increased—Vincristine—muscle cancer	0.000436	0.00383	CcSEcCtD
Desipramine—Abdominal pain—Vincristine—muscle cancer	0.000436	0.00383	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000436	0.00383	CcSEcCtD
Desipramine—Erectile dysfunction—Methotrexate—muscle cancer	0.000434	0.00381	CcSEcCtD
Desipramine—Anorexia—Etoposide—muscle cancer	0.000426	0.00374	CcSEcCtD
Desipramine—Diarrhoea—Dactinomycin—muscle cancer	0.000423	0.00371	CcSEcCtD
Desipramine—Drowsiness—Methotrexate—muscle cancer	0.00042	0.00369	CcSEcCtD
Desipramine—Depression—Methotrexate—muscle cancer	0.000419	0.00368	CcSEcCtD
Desipramine—Hypotension—Etoposide—muscle cancer	0.000418	0.00367	CcSEcCtD
Desipramine—Stomatitis—Methotrexate—muscle cancer	0.000409	0.0036	CcSEcCtD
Desipramine—HTR2A—head—muscle cancer	0.000407	0.00438	CbGeAlD
Desipramine—Eosinophilia—Doxorubicin—muscle cancer	0.000404	0.00355	CcSEcCtD
Desipramine—Paraesthesia—Etoposide—muscle cancer	0.000402	0.00353	CcSEcCtD
Desipramine—ABCB1—renal system—muscle cancer	0.000399	0.00429	CbGeAlD
Desipramine—Somnolence—Etoposide—muscle cancer	0.000398	0.00349	CcSEcCtD
Desipramine—Asthenia—Vincristine—muscle cancer	0.000396	0.00348	CcSEcCtD
Desipramine—HTR2A—testis—muscle cancer	0.000394	0.00423	CbGeAlD
Desipramine—Vomiting—Dactinomycin—muscle cancer	0.000393	0.00345	CcSEcCtD
Desipramine—Agranulocytosis—Methotrexate—muscle cancer	0.000392	0.00344	CcSEcCtD
Desipramine—Rash—Dactinomycin—muscle cancer	0.00039	0.00342	CcSEcCtD
Desipramine—Decreased appetite—Etoposide—muscle cancer	0.000389	0.00341	CcSEcCtD
Desipramine—Fatigue—Etoposide—muscle cancer	0.000386	0.00339	CcSEcCtD
Desipramine—Constipation—Etoposide—muscle cancer	0.000382	0.00336	CcSEcCtD
Desipramine—Diarrhoea—Vincristine—muscle cancer	0.000378	0.00332	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—muscle cancer	0.000377	0.00331	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—muscle cancer	0.000377	0.00331	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—muscle cancer	0.000371	0.00326	CcSEcCtD
Desipramine—CYP2D6—head—muscle cancer	0.000371	0.00399	CbGeAlD
Desipramine—Feeling abnormal—Etoposide—muscle cancer	0.000369	0.00324	CcSEcCtD
Desipramine—Nausea—Dactinomycin—muscle cancer	0.000367	0.00322	CcSEcCtD
Desipramine—Dizziness—Vincristine—muscle cancer	0.000365	0.00321	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—muscle cancer	0.000364	0.00319	CcSEcCtD
Desipramine—CYP2D6—testis—muscle cancer	0.000359	0.00386	CbGeAlD
Desipramine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000356	0.00313	CcSEcCtD
Desipramine—Urticaria—Etoposide—muscle cancer	0.000355	0.00312	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—muscle cancer	0.000354	0.00311	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—muscle cancer	0.000354	0.00311	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—muscle cancer	0.000354	0.00311	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—muscle cancer	0.000354	0.00311	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—muscle cancer	0.000352	0.00309	CcSEcCtD
Desipramine—Vomiting—Vincristine—muscle cancer	0.000351	0.00308	CcSEcCtD
Desipramine—Rash—Vincristine—muscle cancer	0.000348	0.00306	CcSEcCtD
Desipramine—Dermatitis—Vincristine—muscle cancer	0.000348	0.00305	CcSEcCtD
Desipramine—Headache—Vincristine—muscle cancer	0.000346	0.00304	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—muscle cancer	0.000339	0.00298	CcSEcCtD
Desipramine—Alopecia—Methotrexate—muscle cancer	0.000333	0.00293	CcSEcCtD
Desipramine—Nausea—Vincristine—muscle cancer	0.000328	0.00288	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—muscle cancer	0.000326	0.00287	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000325	0.00285	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—muscle cancer	0.000321	0.00282	CcSEcCtD
Desipramine—Asthenia—Etoposide—muscle cancer	0.000321	0.00282	CcSEcCtD
Desipramine—Pruritus—Etoposide—muscle cancer	0.000316	0.00278	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—muscle cancer	0.000309	0.00272	CcSEcCtD
Desipramine—Diarrhoea—Etoposide—muscle cancer	0.000306	0.00269	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—muscle cancer	0.000305	0.00267	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—muscle cancer	0.000304	0.00267	CcSEcCtD
Desipramine—Flushing—Doxorubicin—muscle cancer	0.000303	0.00266	CcSEcCtD
Desipramine—ABCB1—bone marrow—muscle cancer	0.000302	0.00325	CbGeAlD
Desipramine—Malaise—Methotrexate—muscle cancer	0.000296	0.0026	CcSEcCtD
Desipramine—Dizziness—Etoposide—muscle cancer	0.000296	0.0026	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—muscle cancer	0.000292	0.00256	CcSEcCtD
Desipramine—ABCB1—vagina—muscle cancer	0.000289	0.00311	CbGeAlD
Desipramine—Alopecia—Doxorubicin—muscle cancer	0.000288	0.00253	CcSEcCtD
Desipramine—Convulsion—Methotrexate—muscle cancer	0.000284	0.0025	CcSEcCtD
Desipramine—Vomiting—Etoposide—muscle cancer	0.000284	0.0025	CcSEcCtD
Desipramine—Rash—Etoposide—muscle cancer	0.000282	0.00248	CcSEcCtD
Desipramine—Dermatitis—Etoposide—muscle cancer	0.000282	0.00247	CcSEcCtD
Desipramine—Headache—Etoposide—muscle cancer	0.00028	0.00246	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—muscle cancer	0.000278	0.00244	CcSEcCtD
Desipramine—Discomfort—Methotrexate—muscle cancer	0.000276	0.00242	CcSEcCtD
Desipramine—Confusional state—Methotrexate—muscle cancer	0.00027	0.00237	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—muscle cancer	0.000268	0.00235	CcSEcCtD
Desipramine—ABCB1—head—muscle cancer	0.000267	0.00287	CbGeAlD
Desipramine—Nausea—Etoposide—muscle cancer	0.000266	0.00233	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000264	0.00232	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—muscle cancer	0.000262	0.0023	CcSEcCtD
Desipramine—Agitation—Doxorubicin—muscle cancer	0.000261	0.00229	CcSEcCtD
Desipramine—ABCB1—testis—muscle cancer	0.000258	0.00278	CbGeAlD
Desipramine—Malaise—Doxorubicin—muscle cancer	0.000256	0.00225	CcSEcCtD
Desipramine—Anorexia—Methotrexate—muscle cancer	0.000255	0.00224	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—muscle cancer	0.000251	0.00221	CcSEcCtD
Desipramine—Hypotension—Methotrexate—muscle cancer	0.00025	0.0022	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—muscle cancer	0.000246	0.00216	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—muscle cancer	0.000245	0.00216	CcSEcCtD
Desipramine—Insomnia—Methotrexate—muscle cancer	0.000242	0.00213	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—muscle cancer	0.000241	0.00212	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—muscle cancer	0.000241	0.00211	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—muscle cancer	0.000239	0.0021	CcSEcCtD
Desipramine—Somnolence—Methotrexate—muscle cancer	0.000238	0.00209	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—muscle cancer	0.000237	0.00208	CcSEcCtD
Desipramine—Dyspepsia—Methotrexate—muscle cancer	0.000236	0.00207	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—muscle cancer	0.000234	0.00205	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—muscle cancer	0.000233	0.00205	CcSEcCtD
Desipramine—Oedema—Doxorubicin—muscle cancer	0.000232	0.00204	CcSEcCtD
Desipramine—Fatigue—Methotrexate—muscle cancer	0.000231	0.00203	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000227	0.00199	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—muscle cancer	0.000226	0.00199	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—muscle cancer	0.000221	0.00194	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—muscle cancer	0.000221	0.00194	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—muscle cancer	0.000217	0.0019	CcSEcCtD
Desipramine—Urticaria—Methotrexate—muscle cancer	0.000213	0.00187	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—muscle cancer	0.000212	0.00186	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—muscle cancer	0.000212	0.00186	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—muscle cancer	0.00021	0.00184	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—muscle cancer	0.000208	0.00183	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—muscle cancer	0.000206	0.00181	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—muscle cancer	0.000204	0.00179	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—muscle cancer	0.000202	0.00177	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—muscle cancer	0.0002	0.00176	CcSEcCtD
Desipramine—Constipation—Doxorubicin—muscle cancer	0.000198	0.00174	CcSEcCtD
Desipramine—Asthenia—Methotrexate—muscle cancer	0.000192	0.00169	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—muscle cancer	0.000191	0.00168	CcSEcCtD
Desipramine—Pruritus—Methotrexate—muscle cancer	0.00019	0.00166	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—muscle cancer	0.000184	0.00162	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—muscle cancer	0.000183	0.00161	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—muscle cancer	0.000183	0.00161	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—muscle cancer	0.000183	0.00161	CcSEcCtD
Desipramine—Dizziness—Methotrexate—muscle cancer	0.000177	0.00156	CcSEcCtD
Desipramine—Vomiting—Methotrexate—muscle cancer	0.00017	0.0015	CcSEcCtD
Desipramine—Rash—Methotrexate—muscle cancer	0.000169	0.00148	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—muscle cancer	0.000169	0.00148	CcSEcCtD
Desipramine—Headache—Methotrexate—muscle cancer	0.000168	0.00147	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—muscle cancer	0.000166	0.00146	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—muscle cancer	0.000164	0.00144	CcSEcCtD
Desipramine—Nausea—Methotrexate—muscle cancer	0.000159	0.0014	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—muscle cancer	0.000159	0.00139	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—muscle cancer	0.000153	0.00135	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—muscle cancer	0.000147	0.0013	CcSEcCtD
Desipramine—Rash—Doxorubicin—muscle cancer	0.000146	0.00128	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—muscle cancer	0.000146	0.00128	CcSEcCtD
Desipramine—Headache—Doxorubicin—muscle cancer	0.000145	0.00128	CcSEcCtD
Desipramine—Nausea—Doxorubicin—muscle cancer	0.000138	0.00121	CcSEcCtD
